Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 08:34 am Sale | 2023-12-31 | 13G | Allakos Inc. ALLK | Deep Track Capital LP | 2,510,736 2.870% | -2,489,264 (-49.79%) | Filing History |
| 2024-02-14 08:33 am Sale | 2023-12-31 | 13G | Albireo Pharma, Inc. ALBO | Deep Track Capital LP | 0 0.000% | -1,704,000 (Position Closed) | Filing History |
| 2024-02-14 08:33 am Purchase | 2023-12-31 | 13G | Agenus Inc. AGEN | Deep Track Capital LP | 1,584,877 8.310% | 209,227 (+15.21%) | Filing History |
| 2024-02-14 08:32 am Sale | 2023-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS | Deep Track Capital LP | 0 0.000% | -3,952,000 (Position Closed) | Filing History |
| 2024-02-12 4:01 pm Purchase | 2024-02-02 | 13G | Invivyd, Inc. IVVD | Deep Track Capital LP | 9,000,000 7.560% | 9,000,000 (New Position) | Filing History |
| 2024-01-26 4:20 pm Purchase | 2024-01-16 | 13G | Allakos Inc. ALLK | Deep Track Capital LP | 5,000,000 5.720% | 2,489,264 (+99.14%) | Filing History |
| 2024-01-26 09:21 am Sale | 2023-12-31 | 13G | Allakos Inc. ALLK | Deep Track Capital LP | 2,510,736 2.870% | -2,388,443 (-48.75%) | Filing History |
| 2024-01-19 4:38 pm Purchase | 2024-01-11 | 13G | Dyne Therapeutics, Inc. DYN | Deep Track Capital LP | 4,500,000 5.550% | 2,500,000 (+125.00%) | Filing History |
| 2024-01-19 09:08 am Sale | 2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Deep Track Capital LP | 2,000,000 3.260% | -684,200 (-25.49%) | Filing History |
| 2023-12-22 4:04 pm Purchase | 2023-12-14 | 13G | Ocular Therapeutix, Inc. OCUL | Deep Track Capital LP | 9,230,769 8.380% | 9,230,769 (New Position) | Filing History |
| 2023-11-02 4:09 pm Purchase | 2023-10-23 | 13G | Ambrx Biopharma Inc. AMAM | Deep Track Capital LP | 3,710,412 5.650% | 3,710,412 (New Position) | Filing History |
| 2023-11-02 4:08 pm Purchase | 2023-10-23 | 13G | Aligos Therapeutics, Inc. ALGS | Deep Track Capital LP | 291,839 9.990% | 291,839 (New Position) | Filing History |
| 2023-10-30 4:13 pm Purchase | 2023-10-20 | 13G | Abivax S.A. ABVX | Deep Track Capital LP | 4,297,438 6.140% | 4,297,438 (New Position) | Filing History |
| 2023-10-27 4:02 pm Purchase | 2023-10-20 | 13G | Tourmaline Bio, Inc. TRML | Deep Track Capital LP | 1,815,854 8.930% | 1,815,854 (New Position) | Filing History |
| 2023-10-23 4:40 pm Purchase | 2023-10-13 | 13G | RAPT Therapeutics, Inc. RAPT | Deep Track Capital LP | 248,925 5.800% | 248,925 (New Position) | Filing History |
| 2023-10-02 4:32 pm Purchase | 2023-09-22 | 13G | AnaptysBio, Inc. ANAB | Deep Track Capital LP | 1,360,176 5.120% | 1,360,176 (New Position) | Filing History |
| 2023-09-29 4:15 pm Purchase | 2023-09-20 | 13G | HilleVax, Inc. HLVX | Deep Track Capital LP | 2,900,000 6.140% | 2,900,000 (New Position) | Filing History |
| 2023-08-04 4:17 pm Purchase | 2023-07-26 | 13G | Editas Medicine, Inc. EDIT | Deep Track Capital LP | 4,493,416 5.510% | 4,493,416 (New Position) | Filing History |
| 2023-07-28 4:25 pm Purchase | 2023-07-20 | 13G | Terns Pharmaceuticals, Inc. TERN | Deep Track Capital LP | 3,560,000 6.280% | 3,560,000 (New Position) | Filing History |
| 2023-07-24 4:05 pm Purchase | 2023-07-14 | 13G | Apogee Therapeutics, Inc. APGE | Deep Track Capital LP | 3,023,456 8.870% | 3,023,456 (New Position) | Filing History |